- Home
- ANIX vs MLSS Comparison
ANIX vs MLSS Comparison
Compare ANIX & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- MLSS
- Stock Information
- Founded
- ANIX 1982
- MLSS 1989
- Country
- ANIX United States
- MLSS United States
- Employees
- ANIX N/A
- MLSS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- MLSS Industrial Specialties
- Sector
- ANIX Health Care
- MLSS Health Care
- Exchange
- ANIX Nasdaq
- MLSS Nasdaq
- Market Cap
- ANIX 84.7M
- MLSS 74.5M
- IPO Year
- ANIX 1987
- MLSS 1995
- Fundamental
- Price
- ANIX $2.63
- MLSS $0.97
- Analyst Decision
- ANIX Strong Buy
- MLSS Buy
- Analyst Count
- ANIX 3
- MLSS 1
- Target Price
- ANIX $9.00
- MLSS $1.25
- AVG Volume (30 Days)
- ANIX 36.2K
- MLSS 54.4K
- Earning Date
- ANIX 06-03-2025
- MLSS 05-19-2025
- Dividend Yield
- ANIX N/A
- MLSS N/A
- EPS Growth
- ANIX N/A
- MLSS N/A
- EPS
- ANIX N/A
- MLSS N/A
- Revenue
- ANIX N/A
- MLSS $8,629,928.00
- Revenue This Year
- ANIX N/A
- MLSS $29.14
- Revenue Next Year
- ANIX N/A
- MLSS $20.19
- P/E Ratio
- ANIX N/A
- MLSS N/A
- Revenue Growth
- ANIX N/A
- MLSS N/A
- 52 Week Low
- ANIX $2.07
- MLSS $0.58
- 52 Week High
- ANIX $4.20
- MLSS $1.39
- Technical
- Relative Strength Index (RSI)
- ANIX 42.93
- MLSS 50.59
- Support Level
- ANIX $2.70
- MLSS $0.91
- Resistance Level
- ANIX $2.84
- MLSS $1.11
- Average True Range (ATR)
- ANIX 0.16
- MLSS 0.07
- MACD
- ANIX -0.01
- MLSS 0.00
- Stochastic Oscillator
- ANIX 25.62
- MLSS 39.65
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.